✦ LIBER ✦

7147 Efficacy and safety of long-term use of sorafenib: final report of a phase II trial of sorafenib in Japanese patients with unresectable/metastatic renal cell carcinoma

✍ Scribed by Akaza, H.; Naito, S.; Tsukamoto, T.; Murai, M.; Fukino, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overall survival and good tolerability o

✍ Seiji Naito; Taiji Tsukamoto; Masaru Murai; Koichi Fukino; Hideyuki Akaza 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB

Phase I trial of sorafenib in combinatio

✍ Masashi Niwakawa, Katsuyoshi Hashine, Raizo Yamaguchi, Hirofumi Fujii, Yasuo Ham 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 359 KB

A Phase II Trial of Intrapatient Dose-Es

✍ Robert Amato; Jim Zhai; James Willis; Somyata Saxena; Melissa DeFoe 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 705 KB

Erratum to: Phase I trial of sorafenib i

✍ Masashi Niwakawa, Katsuyoshi Hashine, Raizo Yamaguchi, Hirofumi Fujii, Yasuo Ham 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 65 KB

Phase II Placebo-Controlled Randomized D

✍ Ornstein, D.K.; Finley, D.S. 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 56 KB

Efficacy and safety of sorafenib in pati

✍ Jordi Bruix; Jean-Luc Raoul; Morris Sherman; Vincenzo Mazzaferro; Luigi Bolondi; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 934 KB